Skip Navigation

Cardiovascular Research 2004 63(2):313-322; doi:10.1016/j.cardiores.2004.04.003
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Skyschally, A.
Right arrow Articles by Heusch, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skyschally, A.
Right arrow Articles by Heusch, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Coronary microembolization does not induce acute preconditioning against infarction in pigs—the role of adenosine

Andreas Skyschallya, Rainer Schulza, Petra Gresa, Ina Konietzkaa, Claus Martina, Michael Haudeb, Raimund Erbelb and Gerd Heusch*,a

aInstitut für Pathophysiologie, Zentrum für Innere Medizin, Universitätsklinikum Essen, Hufelandstraße 55, 45122 Essen, Germany
bKlinik für Kardiologie, Zentrum Für Innere Medizin, Universitätsklinikum Essen, Hufelandstraße 55, 45122 Essen, Germany

* Corresponding author. Tel.: +49-201-723-4480; fax: +49-201-723-4481. Email address: gerd.heusch{at}uni-essen.de

Objective: After coronary microembolization (ME) adenosine is released from ischemic areas of the microembolized myocardium. This adenosine dilates vessels in adjacent nonembolized myocardium and increases coronary blood flow. For ischemic preconditioning (IP) to protect the myocardium against infarction, an increase in the interstitial adenosine concentration (iADO) prior to the subsequent ischemia/reperfusion is necessary. We hypothesized that the adenosine release after ME is sufficient to increase iADO and protect the myocardium against infarction from subsequent ischemia/reperfusion. We have therefore compared myocardial protection by either coronary microembolization or ischemic preconditioning prior to ischemia/reperfusion. Methods: In anesthetized pigs, the left anterior descending (LAD) was cannulated and perfused from an extracorporeal circuit. In 11 pigs, sustained ischemia was induced by 85% inflow reduction for 90 min (controls). Two other groups of pigs were subjected either to IP (n=8; 10-min ischemia/15-min reperfusion) or coronary ME (n=9; i.c. microspheres; 42 µm Ø; 3000·ml–1·min inflow) prior to sustained ischemia. Coronary venous adenosine concentration (vADO) and iADO (microdialysis) were measured. Infarct size was determined after 2-h reperfusion by triphenyl tetrazolium chloride staining. Results: In pigs subjected to IP, infarct size was reduced to 2.6±1.1% (mean±S.E.M.) vs. 17.0±3.2% in controls. iADO was increased from 2.4±1.3 to 13.1±5.8 µmol·l–1 during the reperfusion following IP. In pigs subjected to ME, at 10 min after ME, coronary blood flow (38.6±3.6 to 53.6±4.3 ml·min–1) and vADO (0.25±0.04 to 0.48±0.07 µmol·l–1) were increased. However, iADO (2.0±0.5 at baseline vs. 2.3±0.6 µmol·l–1 at 10 min after ME) did not increase. Infarct size induced by sustained ischemia following ME (22.5±5.2%) was above that of controls for any given subendocardial blood flow. Conclusion: ME released adenosine into the vasculature and increased coronary blood flow. The failure of iADO to increase with ME possibly explains the lack of protection against infarction after ME.

KEYWORDS Adenosine; Preconditioning; Microcirculation


Time for primary review 15 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
G. Heusch, P. Kleinbongard, D. Bose, B. Levkau, M. Haude, R. Schulz, and R. Erbel
Coronary Microembolization: From Bedside to Bench and Back to Bedside
Circulation, November 3, 2009; 120(18): 1822 - 1836.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Heusch and R. Schulz
Neglect of the coronary circulation: some critical remarks on problems in the translation of cardioprotection
Cardiovasc Res, October 1, 2009; 84(1): 11 - 14.
[Full Text] [PDF]


Home page
Circ. Res.Home page
A. Skyschally, P. Gres, S. Hoffmann, M. Haude, R. Erbel, R. Schulz, and G. Heusch
Bidirectional Role of Tumor Necrosis Factor-{alpha} in Coronary Microembolization: Progressive Contractile Dysfunction Versus Delayed Protection Against Infarction
Circ. Res., January 5, 2007; 100(1): 140 - 146.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Canton, A. Skyschally, R. Menabo, K. Boengler, P. Gres, R. Schulz, M. Haude, R. Erbel, F. Di Lisa, and G. Heusch
Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization
Eur. Heart J., April 1, 2006; 27(7): 875 - 881.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.